Gingival crevicular fluid PGE 2, IL-1ß, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease

• Published in: Clinical biochemistry Vol. 41; no. 10; pp. 863 - 868
• Main Authors: Kardeşler, Levent, Buduneli, Nurcan, Bıyıkoğlu, Başak, Çetinkalp, Şevki, Kütükçüler, Necil
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 2008
• Subjects: Diabetes; ELISA; Gingival crevicular fluid; IL-1beta Periodontal disease; PAI-2; PGE 2; t-PA; IL-1beta Periodontal disease; PGE 2; PAI-2; Diabetes; Gingival crevicular fluid; ELISA; t-PA
• ISSN: 0009-9120; 1873-2933
• DOI: 10.1016/j.clinbiochem.2008.04.013

To evaluate if type 2 diabetes mellitus increase gingival crevicular fluid (GCF) levels of prostaglandin E 2 (PGE 2), interleukin-1beta (IL-1ß), tissue-type plasminogen activator (t-PA), and plasminogen activator inhibitor-2 (PAI-2). Seventeen type 2 diabetic patients with periodontal disease (DM), 17 otherwise healthy periodontally diseased patients (PD) and 17 systemically and periodontally healthy control subjects (H) were enrolled. Clinical periodontal measurements were recorded at six sites/tooth. GCF samples were analyzed by ELISA. Data were tested by statistical tests. DM group revealed lower IL-1ß levels than PD group ( p < 0.01). PGE 2, t-PA and PAI-2 levels were similar in DM and PD groups ( p > 0.05). PGE 2, t-PA levels were higher in DM and PD groups than H group ( p < 0.05). PAI-2 level was higher in DM group than H group ( p < 0.05). GCF total amount of PGE 2 in DM group exhibited significant correlations with all clinical periodontal measurements ( p < 0.05). Type 2 diabetes in this study seems not to increase GCF levels of the evaluated inflammatory mediators.